$AFCG
Advanced Flower Capital Inc. Stock $afcg

$afcg Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000182252322000015 Filed on November 08, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$19.70M	$18.14M
YoY Change	51.4%	70.88%
Cost Of Revenue	$3.892M	$3.825M
YoY Change	37.86%	50.41%
Gross Profit	$15.81M	$14.32M
YoY Change	55.16%	68.96%
Gross Profit Margin	80.25%	78.92%
Selling, General & Admin	$2.028M	$1.490M
YoY Change	22.13%	14.06%
% of Gross Profit	12.83%	10.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.028M	$5.315M
YoY Change	22.13%	38.07%
Operating Profit	$13.78M	$9.002M
YoY Change	61.59%	94.67%
Interest Expense	-$2.031M	$1.644M
YoY Change	1050.5%	15.46%
% of Operating Profit	-14.74%	18.26%
Other Income/Expense, Net	-$8.137M	-$542.0K
YoY Change	537.3%	-17.96%
Pretax Income	$3.615M	$11.65M
YoY Change	-48.92%	46.87%
Income Tax	$676.6K	$200.0K
% Of Pretax Income	18.72%	1.72%
Net Earnings	$2.938M	$11.48M
YoY Change	-58.27%	44.76%
Net Earnings / Revenue	14.91%	63.28%
Basic Earnings Per Share		$0.57
Diluted Earnings Per Share	$0.14	$0.57
COMMON SHARES
Basic Shares Outstanding	20.36M shares	19.86M shares
Diluted Shares Outstanding		20.11M shares

Balance Sheet

Concept	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$140.4M	$36.32M
YoY Change	12.17%	-48.1%
Cash & Equivalents	$140.4M	$36.32M
Short-Term Investments	$0.00
Other Short-Term Assets	$460.8K	$564.0K
YoY Change	-51.45%	44.15%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$140.8M	$36.88M
YoY Change	27.8%	-47.58%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$0.00
YoY Change	-100.0%
Other Assets
YoY Change
Total Long-Term Assets	$378.3M	$434.4M
YoY Change	6.68%	86.04%
TOTAL ASSETS
Total Short-Term Assets	$140.8M	$36.88M
Total Long-Term Assets	$378.3M	$434.4M
Total Assets	$519.2M	$471.3M
YoY Change	11.69%	55.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$836.6K	$1.131M
YoY Change	-45.28%	117.33%
Accrued Expenses	$9.973M	$13.70M
YoY Change	0.52%	17.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$82.23M	$26.25M
YoY Change	-13.0%	-8.8%
LONG-TERM LIABILITIES
Long-Term Debt	$97.13M	$96.96M
YoY Change	0.58%
Other Long-Term Liabilities	$754.1K	$688.7K
YoY Change	10.39%	-0.52%
Total Long-Term Liabilities	$97.89M	$97.65M
YoY Change	0.65%	14006.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$82.23M	$26.25M
Total Long-Term Liabilities	$97.89M	$97.65M
Total Liabilities	$180.1M	$123.9M
YoY Change	-6.08%	320.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.962M	-$1.489M
YoY Change	811.56%
Common Stock	$203.6K	$203.6K
YoY Change	24.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$339.1M	$347.4M
YoY Change
Total Liabilities & Shareholders Equity	$519.2M	$471.3M
YoY Change	11.69%	55.1%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	$2.938M	$11.48M
YoY Change	-58.27%	44.76%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$3.866M	$12.23M
YoY Change	100.01%	11033.23%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$52.18M	-$19.40M
YoY Change	-141.09%	-67.55%
Cash From Investing Activities	$52.18M	-$19.40M
YoY Change	-141.09%	-67.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	48.01M	-2.096M
YoY Change	-70.78%	-141.6%
NET CHANGE
Cash From Operating Activities	3.866M	12.23M
Cash From Investing Activities	52.18M	-19.40M
Cash From Financing Activities	48.01M	-2.096M
Net Change In Cash	104.1M	-9.264M
YoY Change	164.96%	-83.04%
FREE CASH FLOW
Cash From Operating Activities	$3.866M	$12.23M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001822523
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39995
	dei	Entity Registrant Name EntityRegistrantName	AFC GAMMA, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1807125
	dei	Entity Address Address Line1 EntityAddressAddressLine1	525 Okeechobee Blvd., Suite 1650
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
	dei	City Area Code CityAreaCode	561
	dei	Local Phone Number LocalPhoneNumber	510-2390
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
	dei	Trading Symbol TradingSymbol	AFCG
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20364000	shares
CY2022Q3	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	93454875	usd
CY2021Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	74913157	usd
CY2022Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	94076146	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
CY2022Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	16050000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	16050000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15881250	usd
CY2022Q3	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	339164030	usd
CY2021Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	257163496	usd
CY2022Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	2220466	usd
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2530588	usd
CY2022Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5466194	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	2431558	usd
CY2022Q3	us-gaap	Notes Receivable Net NotesReceivableNet	335918302	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	257262526	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36319623	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109246048	usd
CY2022Q3	us-gaap	Interest Receivable InterestReceivable	4442680	usd
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	4412938	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	563984	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	949279	usd
CY2022Q3	us-gaap	Assets Assets	471320735	usd
CY2021Q4	us-gaap	Assets Assets	464848360	usd
CY2022Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	6126430	usd
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4782271	usd
CY2022Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2395833	usd
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	991840	usd
CY2022Q3	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	17640	usd
CY2021Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	usd
CY2022Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11403840	usd
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	8221406	usd
CY2022Q3	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	688676	usd
CY2021Q4	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	683177	usd
CY2022Q3	us-gaap	Management Fee Payable ManagementFeePayable	3824735	usd
CY2021Q4	us-gaap	Management Fee Payable ManagementFeePayable	2823044	usd
CY2022Q3	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	1351666	usd
CY2021Q4	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	1324457	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	1131406	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	1528980	usd
CY2022Q3	us-gaap	Senior Notes SeniorNotes	96964872	usd
CY2021Q4	us-gaap	Senior Notes SeniorNotes	96572656	usd
CY2022Q3	afcg	Line Of Credit Facility Due To Affiliate Current And Noncurrent LineOfCreditFacilityDueToAffiliateCurrentAndNoncurrent	0	usd
CY2021Q4	afcg	Line Of Credit Facility Due To Affiliate Current And Noncurrent LineOfCreditFacilityDueToAffiliateCurrentAndNoncurrent	74845355	usd
CY2022Q3	us-gaap	Liabilities Liabilities	123905098	usd
CY2021Q4	us-gaap	Liabilities Liabilities	191773186	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	125	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	125	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	125	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	125	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20364000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20364000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16442812	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16442812	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	203640	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-168750	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	163866	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	348700927	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	274172934	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1488931	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1092877	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	347415637	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	273075174	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	471320735	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	464848360	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	19785583	usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	10616538	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	60072643	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	24050062	usd
CY2022Q3	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1644088	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18141495	usd
CY2021Q3	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	0	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	5091207	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	0	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10616538	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54981436	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24050062	usd
CY2022Q3	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	432426	usd
CY2021Q3	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	256989	usd
	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	1307969	usd
	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	677439	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3824735	usd
CY2021Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2542936	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	11873516	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5498469	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1050932	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	858663	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3372813	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2028046	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	114062	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	51429	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1221482	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1662001	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	324846	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	396147	usd
	us-gaap	Professional Fees ProfessionalFees	1017525	usd
	us-gaap	Professional Fees ProfessionalFees	726194	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	5314575	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	3849175	usd
	us-gaap	Operating Expenses OperatingExpenses	17485336	usd
	us-gaap	Operating Expenses OperatingExpenses	9914710	usd
CY2022Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	541958	usd
CY2021Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	660612	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3040135	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1372498	usd
CY2022Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2021Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	400000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	450000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	400000	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-637279	usd
CY2021Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1423929	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1561890	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	796368	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11647683	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7930680	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	33344075	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13959222	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	167164	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	349763	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	11480519	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	7930680	usd
	us-gaap	Net Income Loss NetIncomeLoss	32994312	usd
	us-gaap	Net Income Loss NetIncomeLoss	13959222	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.13
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20019760	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16402984	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19687730	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12368977	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20112033	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16776648	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19780003	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12742641	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	11480519	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	7930680	usd
	us-gaap	Net Income Loss NetIncomeLoss	32994312	usd
	us-gaap	Net Income Loss NetIncomeLoss	13959222	usd
CY2022Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2021Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	168750	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11480519	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7930680	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	33163062	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13959222	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	338200365	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9023889	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	114704	usd
CY2022Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.56
CY2022Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	11403840	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	11480519	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	347415637	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	268456722	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5038522	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	51429	usd
CY2021Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.43
CY2021Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	7070409	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	7930680	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	274406944	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	273075174	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	73346205	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1221562	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.67
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	33382866	usd
	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	168750	usd
	us-gaap	Net Income Loss NetIncomeLoss	32994312	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	347415637	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	91647712	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	181520197	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1662001	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.17
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	14374688	usd
	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
	us-gaap	Net Income Loss NetIncomeLoss	13959222	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	274406944	usd
	us-gaap	Net Income Loss NetIncomeLoss	32994312	usd
	us-gaap	Net Income Loss NetIncomeLoss	13959222	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	319140	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3040135	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1372498	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	450000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	400000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1561890	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	796368	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	9710278	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	4038816	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	714471	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1221482	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1662001	usd
	afcg	Payment In Kind Interest PaymentInKindInterest	5051007	usd
	afcg	Payment In Kind Interest PaymentInKindInterest	2787847	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	29742	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	1507427	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-217685	usd
	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	-894159	usd
	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	2521923	usd
	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	10400000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	15900000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1403993	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	1001691	usd
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	2320808	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	27209	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	296040	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-379934	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	366696	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27456066	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7605744	usd
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	127248748	usd
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	156345116	usd
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	0	usd
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	2313130	usd
	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	10600000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	32227904	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	22168395	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-68520844	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-121463591	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75057650	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	185501295	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1711365	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3981098	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	30207932	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	7311779	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	75000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-31861647	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	174208418	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-72926425	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	60350571	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109246048	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9623820	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36319623	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69974391	usd
	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	450000	usd
	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	9450468	usd
	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	5607675	usd
	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	12391624	usd
	afcg	Loans Funded From Amounts Due To Affiliate LoansFundedFromAmountsDueToAffiliate	0	usd
	afcg	Loans Funded From Amounts Due To Affiliate LoansFundedFromAmountsDueToAffiliate	9549625	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2022Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11403840	usd
CY2021Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	2972743	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	41287	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q3	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	95575523	usd
	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P1Y6M
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of loans held for investment at fair value and current expected credit losses (“CECL”).</span></div>
	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	3	loan
CY2021	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	3	loan
CY2022Q3	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	97100000	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	75900000	usd
CY2022Q3	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	95600000	usd
CY2021Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	77600000	usd
	afcg	Loans Held For Investment At Fair Value Funded Of Outstanding Principal LoansHeldForInvestmentAtFairValueFundedOfOutstandingPrincipal	18700000	usd
	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue	3000000.0	usd
CY2022Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	94076146	usd
CY2022Q3	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	93454875	usd
	afcg	Loans Held For Investment At Fair Value Additional Loan Repayments Principal LoansHeldForInvestmentAtFairValueAdditionalLoanRepaymentsPrincipal	1960000	usd
CY2021Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	74913157	usd
CY2021Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	77630742	usd
CY2021	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P2Y2M12D
CY2021Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	77630742	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	2717584	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	2183161	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-1561890	usd
	afcg	Loans Held For Investment At Fair Value Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-1561890	usd
	afcg	Loans Held For Investment At Fair Value Outstanding Principal New Fundings LoansHeldForInvestmentAtFairValueOutstandingPrincipalNewFundings	18737988	usd
	afcg	Loans Held For Investment At Fair Value Original Issue Discount Net Of Costs LoansHeldForInvestmentAtFairValueOriginalIssueDiscountNetOfCosts	479276	usd
	afcg	Loans Held For Investment At Fair Value New Funding LoansHeldForInvestmentAtFairValueNewFunding	18258712	usd
	afcg	Loans Held For Investment At Fair Value Additional Loan Repayments LoansHeldForInvestmentAtFairValueAdditionalLoanRepayments	1960000	usd
	afcg	Loans Held For Investment At Fair Value Amortization Loan Repayments Principal LoansHeldForInvestmentAtFairValueAmortizationLoanRepaymentsPrincipal	1089776	usd
	afcg	Loans Held For Investment At Fair Value Amortization Loan Repayments LoansHeldForInvestmentAtFairValueAmortizationLoanRepayments	1089776	usd
	afcg	Loans Held For Investment At Fair Value Original Issue Discount Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscountAccretionOfOriginalIssueDiscount	1076212	usd
	afcg	Loans Held For Investment At Fair Value Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueAccretionOfOriginalIssueDiscount	1076212	usd
	afcg	Loans Held For Investment At Fair Value Outstanding Principal Payment In Kind Interest LoansHeldForInvestmentAtFairValueOutstandingPrincipalPaymentInKindInterest	2256569	usd
	afcg	Loans Held For Investment At Fair Value Payment In Kind Interest LoansHeldForInvestmentAtFairValuePaymentInKindInterest	2256569	usd
CY2022Q3	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	95575523	usd
CY2022Q3	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	2120648	usd
CY2022Q3	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	621271	usd
CY2022Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	94076146	usd
CY2022Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	94076146	usd
CY2022Q3	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	93454875	usd
CY2022Q3	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	95575523	usd
	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	10	loan
CY2021	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	12	loan
CY2022Q3	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	401100000	usd
CY2021Q4	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	324300000	usd
CY2022Q3	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	349300000	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	270800000	usd
	afcg	Loans Held For Investment At Carrying Value Outstanding Principal New Fundings LoansHeldForInvestmentAtCarryingValueOutstandingPrincipalNewFundings	139600000	usd
CY2022Q3	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.39
CY2021Q4	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.48
CY2022Q3	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	349337390	usd
CY2022Q3	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	10173360	usd
CY2022Q3	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	339164030	usd
	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P2Y8M12D
CY2021Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	270841715	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13678219	usd
CY2021Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	257163496	usd
CY2021	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P3Y4M24D
CY2021Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	270841715	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13678219	usd
CY2021Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	257163496	usd
	afcg	Receivable With Imputed Interest New Funding Face Amount ReceivableWithImputedInterestNewFundingFaceAmount	139571920	usd
	afcg	Receivable With Imputed Interest Discount On New Funding ReceivableWithImputedInterestDiscountOnNewFunding	5128400	usd
	afcg	Receivable With Imputed Interest New Funding Net Amount ReceivableWithImputedInterestNewFundingNetAmount	134443520	usd
	afcg	Accretion Of Original Issue Discount Principle AccretionOfOriginalIssueDiscountPrinciple	0	usd
	afcg	Receivable With Accretion Of Original Issue Discount Premium ReceivableWithAccretionOfOriginalIssueDiscountPremium	8633259	usd
	afcg	Accretion Of Original Issue Discount Net Amount AccretionOfOriginalIssueDiscountNetAmount	8633259	usd
	afcg	Receivable With Imputed Interest Loan Repayments Face Amount ReceivableWithImputedInterestLoanRepaymentsFaceAmount	52014211	usd
	afcg	Receivable With Imputed Interest Loan Repayments Original Issue Discount ReceivableWithImputedInterestLoanRepaymentsOriginalIssueDiscount	0	usd
	afcg	Receivable With Imputed Interest Loan Repayments ReceivableWithImputedInterestLoanRepayments	52014211	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	10000000	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Original Issue Discount ReceivableWithImputedInterestSaleOfLoansOriginalIssueDiscount	0	usd
	afcg	Receivable With Sale Of Loans Net Amount ReceivableWithSaleOfLoansNetAmount	10000000	usd
	afcg	Receivable With Paid In Kind Interest Face Amount ReceivableWithPaidInKindInterestFaceAmount	2768252	usd
	afcg	Receivable With Paid In Kind Interest Original Issue Discount ReceivableWithPaidInKindInterestOriginalIssueDiscount	0	usd
	afcg	Receivable With Paid In Kind Interest Net Amount ReceivableWithPaidInKindInterestNetAmount	2768252	usd
	afcg	Receivable With Imputed Interest Amortization Payments ReceivableWithImputedInterestAmortizationPayments	1830286	usd
	afcg	Receivable With Imputed Interest Amortization Payments Original Issue Discount ReceivableWithImputedInterestAmortizationPaymentsOriginalIssueDiscount	0	usd
	afcg	Receivable With Imputed Interest Loan Amortization Payments ReceivableWithImputedInterestLoanAmortizationPayments	1830286	usd
CY2022Q3	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	349337390	usd
CY2022Q3	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	10173360	usd
CY2022Q3	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	339164030	usd
CY2022Q3	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	349337390	usd
CY2022Q3	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	10173360	usd
CY2022Q3	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	339164030	usd
CY2022Q3	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2021Q4	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2022Q3	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000	usd
CY2021Q4	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000	usd
CY2022Q3	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2200000	usd
CY2021Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2500000	usd
	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	300000	usd
CY2022Q3	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1873	usd
CY2022Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	2220466	usd
CY2021Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2533266	usd
CY2021Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	2678	usd
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2530588	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	337114	usd
	afcg	Payments On Loans Receivable Original Issue Discount PaymentsOnLoansReceivableOriginalIssueDiscount	0	usd
	afcg	Payments On Loans Receivable Carrying Value PaymentsOnLoansReceivableCarryingValue	337114	usd
	afcg	Accretion Of Original Issue Discount At Principle AccretionOfOriginalIssueDiscountAtPrinciple	0	usd
	afcg	Accretion Of Original Issue Discount AccretionOfOriginalIssueDiscount	805	usd
	afcg	Accretion Of Original Issue Discount At Carrying Value AccretionOfOriginalIssueDiscountAtCarryingValue	805	usd
	afcg	Paid In Kind Interest Principal PaidInKindInterestPrincipal	26187	usd
	afcg	Paid In Kind Interest Original Issue Discount PaidInKindInterestOriginalIssueDiscount	0	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	26187	usd
CY2022Q3	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2222339	usd
CY2022Q3	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	92928263	usd
CY2022Q3	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	222686927	usd
CY2022Q3	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	25769306	usd
CY2022Q3	afcg	Loans Held For Investment And Financing Receivable Before Allowance For Credit Loss LoansHeldForInvestmentAndFinancingReceivableBeforeAllowanceForCreditLoss	341384496	usd
CY2022Q3	afcg	Interest Receivables InterestReceivables	3811696	usd
CY2021Q4	afcg	Interest Receivables InterestReceivables	3562566	usd
CY2022Q3	afcg	Payment In Kind Receivable PaymentInKindReceivable	490284	usd
CY2021Q4	afcg	Payment In Kind Receivable PaymentInKindReceivable	554357	usd
CY2022Q3	afcg	Unused Fees Receivable UnusedFeesReceivable	140700	usd
CY2021Q4	afcg	Unused Fees Receivable UnusedFeesReceivable	296015	usd
CY2022Q3	us-gaap	Interest Receivable InterestReceivable	4442680	usd
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	4412938	usd
	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	3	loan
CY2021	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	7	loan
CY2022Q3	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	3000000	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	8600000	usd
CY2021Q3	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	1800000	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	2500000	usd
CY2022Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	5186615	usd
CY2021Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	5547863	usd
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4782271	usd
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1325750	usd
CY2021Q4	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	363659505	usd
CY2022Q3	us-gaap	Contractual Obligation ContractualObligation	56161159	usd
CY2022Q3	afcg	New Reserves Interest NewReservesInterest	3970958	usd
CY2021Q3	afcg	New Reserves Interest NewReservesInterest	4525468	usd
	afcg	New Reserves Interest NewReservesInterest	9970958	usd
	afcg	New Reserves Interest NewReservesInterest	9450468	usd
CY2022Q3	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	3031143	usd
CY2021Q3	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	1819036	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	8626799	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	2521923	usd
CY2022Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	6126430	usd
CY2021Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	8254295	usd
CY2022Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	6126430	usd
CY2021Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	8254295	usd
CY2022Q2	afcg	Line Of Credit Facility Accordion Feature Increase Limit LineOfCreditFacilityAccordionFeatureIncreaseLimit	100000000.0	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	0	usd
	us-gaap	Interest Expense InterestExpense	0	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1437500	usd
CY2022Q3	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	0	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	206588	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1644088	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	4316319	usd
	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	60417	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	714471	usd
	us-gaap	Interest Expense InterestExpense	5091207	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q3	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	502184382	usd
CY2021Q4	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	419198125	usd
CY2022Q3	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	446023223	usd
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	55538620	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	123900000	usd
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3000000	shares
CY2022Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	20.50
CY2022Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	61500000	usd
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3291832	shares
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	67500000	usd
CY2022Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	63000000.0	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.18
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	300652	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	183114	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	2068469	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1449518	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	82549	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	28396	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2286572	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1604236	shares
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	100000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1200000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	100000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1700000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2316106	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5511	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.90
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	24023	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.20
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2286572	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1613098	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8862	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.90
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1604236	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1604236	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	742000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.46
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5511	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.90
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	54153	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.12
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2286572	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	926898	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.91
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	689200	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.31
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	11862	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.01
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1604236	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	11480519	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	7930680	usd
	us-gaap	Net Income Loss NetIncomeLoss	32994312	usd
	us-gaap	Net Income Loss NetIncomeLoss	13959222	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20019760	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16402984	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19687730	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12368977	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20112033	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16776648	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19780003	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12742641	shares
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.13
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	afcg	Exercise Tax As A Percentage Of Undistributed Ordinary Income And Net Capital Gains ExerciseTaxAsAPercentageOfUndistributedOrdinaryIncomeAndNetCapitalGains	0.04
CY2022Q3	afcg	Exercise Tax As A Percentage Of Undistributed Ordinary Income And Net Capital Gains ExerciseTaxAsAPercentageOfUndistributedOrdinaryIncomeAndNetCapitalGains	0.04
CY2022Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	94076146	usd
CY2022Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	94076146	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	77096319	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15900000	usd
	afcg	Debt Securities Held At Fair Value Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueChangeInAccumulatedOtherComprehensiveIncome	200000	usd
CY2021Q4	afcg	Debt Securities Held At Fair Value Outstanding Principal Amount DebtSecuritiesHeldAtFairValueOutstandingPrincipalAmount	15000000	usd
CY2021Q4	afcg	Debt Securities Held At Fair Value Original Issue Discount DebtSecuritiesHeldAtFairValueOriginalIssueDiscount	1050000	usd
CY2021Q4	afcg	Debt Securities Held At Fair Value Unrealized Gains Losses DebtSecuritiesHeldAtFairValueUnrealizedGainsLosses	-168750	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15881250	usd
	afcg	Debt Securities Held At Fair Value Outstanding Principal Change In Realized Gains Losses On Loans At Fair Value Net DebtSecuritiesHeldAtFairValueOutstandingPrincipalChangeInRealizedGainsLossesOnLoansAtFairValueNet	0	usd
	afcg	Debt Securities Held At Fair Value Original Issue Discount Realized Gains Losses On Loans At Fair Value Net DebtSecuritiesHeldAtFairValueOriginalIssueDiscountRealizedGainsLossesOnLoansAtFairValueNet	-150000	usd
	afcg	Debt Securities Held At Fair Value Realized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net DebtSecuritiesHeldAtFairValueRealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	0	usd
	afcg	Debt Securities Held At Fair Value Change In Realized Gains Losses On Loans At Fair Value Net DebtSecuritiesHeldAtFairValueChangeInRealizedGainsLossesOnLoansAtFairValueNet	-150000	usd
	afcg	Debt Securities Held At Fair Value Value Outstanding Principal Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueValueOutstandingPrincipalChangeInAccumulatedOtherComprehensiveIncome	0	usd
	afcg	Debt Securities Held At Fair Value Original Issue Discount Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueOriginalIssueDiscountChangeInAccumulatedOtherComprehensiveIncome	0	usd
	afcg	Debt Securities Held At Fair Value Unrealized Gains Losses Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueUnrealizedGainsLossesChangeInAccumulatedOtherComprehensiveIncome	168750	usd
	afcg	Debt Securities Held At Fair Value Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueChangeInAccumulatedOtherComprehensiveIncome	168750	usd
	afcg	Debt Securities Held At Fair Value Value Outstanding Principal Sale Of Securities DebtSecuritiesHeldAtFairValueValueOutstandingPrincipalSaleOfSecurities	15000000	usd
	afcg	Debt Securities Held At Fair Value Original Issue Discount Sale Of Securities DebtSecuritiesHeldAtFairValueOriginalIssueDiscountSaleOfSecurities	900000	usd
	afcg	Debt Securities Held At Fair Value Unrealized Gains Losses Sale Of Securities DebtSecuritiesHeldAtFairValueUnrealizedGainsLossesSaleOfSecurities	0	usd
	afcg	Debt Securities Held At Fair Value Sale Of Securities DebtSecuritiesHeldAtFairValueSaleOfSecurities	15900000	usd
CY2022Q3	afcg	Debt Securities Held At Fair Value Outstanding Principal Amount DebtSecuritiesHeldAtFairValueOutstandingPrincipalAmount	0	usd
CY2022Q3	afcg	Debt Securities Held At Fair Value Original Issue Discount DebtSecuritiesHeldAtFairValueOriginalIssueDiscount	0	usd
CY2022Q3	afcg	Debt Securities Held At Fair Value Unrealized Gains Losses DebtSecuritiesHeldAtFairValueUnrealizedGainsLosses	0	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15881250	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15881250	usd
CY2022Q3	afcg	Incentive Compensation IncentiveCompensation	2900000	usd
	afcg	Incentive Compensation IncentiveCompensation	9300000	usd
CY2021Q3	afcg	Incentive Compensation IncentiveCompensation	1800000	usd
	afcg	Incentive Compensation IncentiveCompensation	3900000	usd
CY2022Q3	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	1318563	usd
CY2021Q3	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	1030718	usd
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	3869023	usd
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	2301924	usd
CY2022Q3	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	432426	usd
CY2021Q3	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	256989	usd
	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	1307969	usd
	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	677439	usd
CY2022Q3	afcg	Related Party Transaction Base Management Fees Net RelatedPartyTransactionBaseManagementFeesNet	886137	usd
CY2021Q3	afcg	Related Party Transaction Base Management Fees Net RelatedPartyTransactionBaseManagementFeesNet	773729	usd
	afcg	Related Party Transaction Base Management Fees Net RelatedPartyTransactionBaseManagementFeesNet	2561054	usd
	afcg	Related Party Transaction Base Management Fees Net RelatedPartyTransactionBaseManagementFeesNet	1624485	usd
CY2022Q3	afcg	Incentive Compensation IncentiveCompensation	2938598	usd
CY2021Q3	afcg	Incentive Compensation IncentiveCompensation	1769207	usd
	afcg	Incentive Compensation IncentiveCompensation	9312462	usd
	afcg	Incentive Compensation IncentiveCompensation	3873984	usd
CY2022Q3	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	910243	usd
CY2021Q3	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	625711	usd
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	2790846	usd
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	1415217	usd
CY2022Q3	us-gaap	Related Party Costs RelatedPartyCosts	4734978	usd
CY2021Q3	us-gaap	Related Party Costs RelatedPartyCosts	3168647	usd
	us-gaap	Related Party Costs RelatedPartyCosts	14664362	usd
	us-gaap	Related Party Costs RelatedPartyCosts	6913686	usd
	afcg	Number Of Co Invested Loans Held NumberOfCoInvestedLoansHeld	5	loan

Files In Submission

Name	View Source	Status
0001822523-22-000015-index-headers.html	Edgar Link	pending
0001822523-22-000015-index.html	Edgar Link	pending
0001822523-22-000015.txt	Edgar Link	pending
0001822523-22-000015-xbrl.zip	Edgar Link	pending
afcg-20220930.htm	Edgar Link	pending
afcg-20220930.xsd	Edgar Link	pending
afcg-20220930xex311.htm	Edgar Link	pending
afcg-20220930xex312.htm	Edgar Link	pending
afcg-20220930xex321.htm	Edgar Link	pending
afcg-20220930xex322.htm	Edgar Link	pending
afcg-secondamendmenttoarma.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
afcg-20220930_def.xml	Edgar Link	unprocessable
afcg-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
afcg-20220930_lab.xml	Edgar Link	unprocessable
afcg-20220930_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
afcg-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AFCG
Advanced Flower Capital Inc. Stock $afcg

2022 Q4 Form 10-Q Financial Statement

#000182252322000015 Filed on November 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG Advanced Flower Capital Inc. Stock $afcg

2022 Q4 Form 10-Q Financial Statement

#000182252322000015 Filed on November 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG
Advanced Flower Capital Inc. Stock $afcg